Roche seeks reimbursement for Gazyva in lupus nephritis in Korea

Coverage, in order

1. 1d ago
   Korea Biomedical Review South Korea obscure

   Roche seeks reimbursement for Gazyva in lupus nephritis in Korea

   Roche Korea is seeking national health insurance reimbursement for Gazyva (obinutuzumab) in lupus nephritis after the drug was approved for the condition in June.The company said Tuesday it has established a dedicated immunology and rheumatology business unit, expanding its focus beyond oncology as

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.